Lisata Therapeutics, Inc.
- LSTA
- NASDAQ
- Biotechnology
- Cell Therapy
- Regenerative Medicine
$1.03
Today −3.74%Quote Oct 16, 2026, 08:00 PM UTC
−40.80%over the last month
Max drawdown −41.4%From 1-month high −40.8%3 months −70.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$9.3M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$1.02
1.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about LSTAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
21
Founded
1980